The IL-22 is an alpha helical cytokine and is considered to be a member of the IFN-IL-10 family, which includes IL-19, IL-20, IL-24, IL-26, Il-28, IL-29 and interferons of type I and II. The IL-22 is produced mainly by...
The IL-22 is an alpha helical cytokine and is considered to be a member of the IFN-IL-10 family, which includes IL-19, IL-20, IL-24, IL-26, Il-28, IL-29 and interferons of type I and II. The main source of L-IL-22 is activated T cells and NK cells. In humans, the IL-22 gene is found on the q arm of chromosome 12 and is structurally bound to l的IL10. The HIL-22 act by engaging the heterodimeric receptor complex composed of the primary receptor IL-22R1 and the accessory receptor IL-10R2. The IL-22R1 also binds the IL-20 and IL-24; the IL-10R2 also binds the IL-10, IL-27, IL-28 and IL-29. The binding of the IL-22 to its receptor complex induces signal transduction, particularly via the JAK-STAT channel. In addition to the membrane-bound IL-22R1/IL-10R2 complex, it has been found that a single-chain soluble IL-22 receptor called IL-22BP antagonizes IL-22 bonding and signalling. The IL-22 does not appear to directly influence immune cells, and the main targets of cytokine appear to be non-immune cells. The effects of the IL-22 include the induction of acute phase reagents and antimicrobial proteins, as well as increased keratinocyte mobility. The IL-22 is strongly expressed during chronic inflammation and has been found to activate intracellular kinases and transcription factors. The IL-22 is essential for the defence of the host against infections of extracellular pathogens and promotes wound healing reactions. The IL-22 is regulated at the top in activated T cells. The IL-22 has been reported as a mediator of the IL-23-induced acanthosis and skin inflammation by activation of STAT3.
Sensitivity
Sensitivity of the dosage: 20 pg/ml.
Measurement range
Dose range: 20 to 6,000 pg/ml.
Duration of dosing
Total duration of dosing: 4 h 45 min.
Reproducibility
Coefficient of intradose variation < 10%, interdose < 12%.
Technical specifications
| General |
| Brand | Invitrogen |
| Supplier ref. (Fisher Scientific) | 17788253 |
| Specifications |
| Accession number | P47878 |
| Dose range | 20 to 6 000 pg/ml |
| Sensitivity of the dosage | 20 pg/ml |
| Conjugate | Biotin |
| Product type | ELISA |
| Type of sample | Plasma, Serum, Surnatant |
| For use with (equipment) | Colorimetric microplate reader |
| Genetic identification (Enter) | 595104 |
| Gene symbol(s) | IL22 |
| Coefficient of inter-dose variation | < 12% |
| Coefficient of intra-dose variation | < 10% |
| Contents of kits | 96-well pre-coated sheetings, etc., at the same time as the pre-casting plate, at the same time as the pre-casting plate. |
| Marker or dye | HRP |
| Quantity | 10 x 96 tests |
| Regulatory status | RUO |
| Target | IL-22 |
| Test time | 1 h 20 min |
| Physical characteristics |
| Volume of sample | Plasma, 50 μl-Surnatant, 50 μl-Serum, 50 μl |
| Storage and shipping |
| Storage conditions | 2°C to 8°C |
| Total duration of dosing | 4 h 45 min |
Origin and customs
| Manufacturer ref. | ES13RBX10 |
|---|
| Country of origin | United States |
|---|
| HS customs code | 3002 12 00 00 |
|---|
A question or a specific configuration?
Contact us for a quote.